"' Asenapine "', sold under the trade names "'Saphris "'and "'Sycrest "', is an atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder.
12.
F ) The signs and symptoms could not be better explained by an eventual previous psychiatric / neurological condition unfavorable natural evolution ( i . e ., Primary Refractory or poor prognosis Schizophrenia; severe Acute Mania; Dementia with Psychotic Symptoms ) or by Neuroleptic Dysphoria.
13.
"' Remoxipride "'( "'Roxiam "') is an atypical antipsychotic ( although according to some sources it is a typical antipsychotic ) which was previously used in Europe for the treatment of schizophrenia and acute mania but was withdrawn due to toxicity concerns ( incidence of aplastic anemia in 1 / 10, 000 patients ).
